These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 9631366

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
    Song SY, Kim WS, Kim K, Jung CW, Im YH, Kim HJ, Kang WK, Lee HG, Kwon OJ, Rhee CH, Park CH, Park K.
    Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
    [Abstract] [Full Text] [Related]

  • 23. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
    Rey F, Astoul P, Marqueste L, Petite JM, Boutin C, Viallat JR.
    Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
    [Abstract] [Full Text] [Related]

  • 24. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
    Gatzemeier U, Heckmayer M, Neuhauss R, Schlüter I, von Pawel J, Wagner H, Dreps A.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.
    Laohavinij S, Maoleekoonpairoj S, Cheirsilpa A, Maneechavakajorn J, Sirachainant E, Arpornvivat W, Jaisathaporn K, Ratanatharathorn V.
    Lung Cancer; 1999 Dec; 26(3):175-85. PubMed ID: 10598928
    [Abstract] [Full Text] [Related]

  • 37. Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.
    Kosmas C, Tsavaris NB, Malamos NA, Vadiaka M, Koufos C.
    J Clin Oncol; 2001 Jan 01; 19(1):119-26. PubMed ID: 11134204
    [Abstract] [Full Text] [Related]

  • 38. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA, Goss PE, Latreille J, Stewart D, Logan D, Evans WK, Maroun J, Warner E.
    Semin Oncol; 1990 Apr 01; 17(2 Suppl 4):19-23. PubMed ID: 2159185
    [Abstract] [Full Text] [Related]

  • 39. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
    Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F, Schäfer-Prokop C, Pokrajac B, Schmeikal S, Maier A, Ambrosch G, Woltsche M, Minar W, Pirker R.
    Lung Cancer; 2006 Oct 01; 54(1):63-7. PubMed ID: 16926060
    [Abstract] [Full Text] [Related]

  • 40. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH, Paul DM, Hande KR, DeVore R.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.